DT Cloud Acquisition Corp. Updates on Maius Pharmaceutical Merger, Announces $150,000 Private Placement with Pubco
DT Cloud Acquisition Corp. announced an update regarding its previously disclosed business combination with Maius Pharmaceutical Co., Ltd. According to a recent filing, DT Cloud Acquisition Corp. has entered into a Subscription Agreement with Maius, Pubco, and an investor. Under this agreement, the investor will purchase 15,000 ordinary shares of Pubco at $10.00 per share in a private placement. The completion of this private placement is contingent on the closing of the broader business combination transaction involving DT Cloud Acquisition Corp., Maius, and related entities. The company stated that these steps are part of its ongoing efforts to finalize the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DT Cloud Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-016335), on September 30, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。